Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt support for Starboard’s turnaround campaign. Starboard’s Jeff Smith revealed ...

Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their ...

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

Starboard has amassed a stake worth about $1 billion, according to The Wall Street Journal, and is pressuring the firm to ...

Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for ...

On Thursday, Starboard CEO Jeff Smith, accused Pfizer of skulduggery in forcing the pair to withdraw their support. He claimed that Read and D’Amelio had been contacted by company representatives, who ...

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.